BioLife Solutions (BLFS) Misses Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $36.81 -0.11%
EPS Growth %: +400.0%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +400.0%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.20), $0.11 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $33.8 million versus the consensus estimate of $31.61 million.
GUIDANCE:
BioLife Solutions sees FY2021 revenue of $115-119 million, versus the consensus of $114.4 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade
- Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
